Schizophrenia-Psychotic Disorders & Antipsychotics

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3! - Disturbed Homeostasis in Patients with Acute Psychosis

Hatta, Kotaro; Usui, Chie; Nakamura, Hiroyuki

Current Psychiatry Reviews, Volume 4, Number 4, November 2008, pp. 190-195(6)

 

3! - Subunit-Selective Modulation of GABA Type A Receptor Neurotransmission and Cognition in Schizophrenia

David A. Lewis, Raymond Y. Cho, Cameron S. Carter, Kevin Eklund, Sarah Forster, Mary Ann Kelly, and Debra Montrose

Am J Psychiatry 2008; 165:1585-1593

4 - The Acute Efficacy of Aripiprazole Across the Symptom Spectrum of Schizophrenia: A Pooled Post Hoc Analysis From 5 Short-Term Studies

Philip G. Janicak, Ira D. Glick, Stephen R. Marder, David T. Crandall, Robert D. McQuade, Ronald N. Marcus, James M. Eudicone, and Sheila Assunção-Talbott

J Clin Psychiatry December 2, 2008: e1-e11

 

3! - Relationships Between Obsessive-Compulsive Symptomatology and Severity of Psychosis in Schizophrenia: A Systematic Review and Meta-Analysis

Ruth Cunill, Xavier Castells, and Daphne Simeon

J Clin Psychiatry December 2, 2008: e1-e13

 

3! - Antipsychotic Polypharmacy in Patients With Schizophrenia in a Brief Hospitalization Unit

Lerma-Carrillo, Ivan; de Pablo Bruhlmann, Silvia; del Pozo, Marta Leonor; Pascual-Pinazo, Fernando; Molina, Juan D; Baca-Garcia, Enrique

Clinical Neuropharmacology. 31(6):319-332, November/December 2008

3 - Variability of the In Vivo Metabolism of Clozapine

Raedler, Thomas J; Hinkelmann, Kim; Wiedemann, Klaus

Clinical Neuropharmacology. 31(6):347-352, November/December 2008

3 - Polypharmacy With Second-Generation Antipsychotics: A Review of Evidence

Pandurangi, Anand K; Dalkilic, Alican

Journal of Psychiatric Practice. 14(6):345-367, November 2008

3 - Clinical characteristics influencing age at onset in psychotic disorders

Dost Öngür, Lewei Lin and Bruce M. Cohen

Comprehensive Psychiatry. Volume 50, Issue 1, January-February 2009, Pages 13-19

 

3! - BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia

Yona Geffen, Abraham Nudelman, Irit Gil-Ad, Ada Rephaeli, Mei Huang, Kinneret Savitsky, Leah Klapper, Ilan Winkler, Herbert Y. Meltzer and Abraham Weizman

European Neuropsychopharmacology. Volume 19, Issue 1, January 2009, Pages 1-13

 

5< - Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophrenia

Rael D. Strous, Michael S. Ritsner, Shmuel Adler, Yael Ratner, Rachel Maayan, Moshe Kotler, Herbert Lachman and Abraham Weizman

European Neuropsychopharmacology. Volume 19, Issue 1, January 2009, Pages 14-22

 

GRATIS 3! - The metabolic syndrome and schizophrenia

J. M. Meyer, S. M. Stahl

Acta Psychiatrica Scandinavica. Volume 119 Issue 1, Pages 4 - 14

 

GRATIS 3 - Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis

B. Arranz, L. San, N. Ramírez, R. M. Dueñas, V. Perez, J. Salavert, I. Corripio, E. Alvarez

Acta Psychiatrica Scandinavica. Volume 119 Issue 1, Pages 71 - 77

 

5 - A Meta-Analysis of the Risk of Acute Extrapyramidal Symptoms With Intramuscular Antipsychotics for the Treatment of Agitation

Theodore D. Satterthwaite, Daniel H. Wolf, Robert A. Rosenheck, Raquel E. Gur, and Stanley N. Caroff

J Clin Psychiatry December 2, 2008: e1-e11

 

3 - Schizophrenia and physical health problems

Y. von Hausswolff-Juhlin, M. Bjartvei, E. Lindström, P. Jones

Acta Psychiatrica Scandinavica. Volume 119 Issue s438, Pages 15 - 21

 

5 - Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM

Lancet. 2008 Dec 4. [Epub ahead of print]

 

3! - Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms

M Poyurovsky, I Glick, and LM Koran

Journal of Psychopharmacology. First published on December 12, 2008

GRATIS 3! - Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature

Daniel J Abrams, Donald C Rojas, David B Arciniegas

Neuropsychiatric Disease and Treatment On-Line Early 28-11-2008

 

3 - Clozapine attenuates disruptions in response inhibition and task efficiency induced by repeated phencyclidine administration in the intracranial self-stimulation procedure

Nurith Amitai, Svetlana Semenova and Athina Markou

European Journal of Pharmacology. Volume 602, Issue 1, 5 January 2009, Pages 78-84

 

5! - Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia

Daniel E Casey, David G Daniel, Carol Tamminga, John M Kane, Tram Tran-Johnson, Patricia Wozniak, Walid Abi-Saab, Jeff Baker, Laura Redden, Nicholas Greco and Mario Saltarelli

Neuropsychopharmacology advance online publication 3 December 2008

 

5 - Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial

Sidney Zisook, John W. Kasckow, Shahrokh Golshan, Ian Fellows, Ellen Solorzano, David Lehman, Somaia Mohamed, and Dilip V. Jeste

J Clin Psychiatry December 16, 2008: e1-e10

 

4 - The Moderating Impact of Ethnicity on Metabolic Outcomes During Treatment With Olanzapine and Aripiprazole in Patients With Schizophrenia

Jonathan M. Meyer, Lisa C. Rosenblatt, Edward Kim, Ross A. Baker, and Richard Whitehead

J Clin Psychiatry December 16, 2008: e1-e8

 

3! - Increased grey matter densities in schizophrenia patients with negative symptoms after treatment with quetiapine: a voxel-based morphometry study

Stip, Emmanuel; Mancini-Marie, Adham; Letourneau, Genevieve; Fahim, Cherine; Mensour, Boualem; Crivello, Fabrice; Dollfus, Sonia

International Clinical Psychopharmacology. 24(1):34-41, January 2009

3 - Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-d-aspartic acid receptor up-regulation

Laura Gray, Maarten van den Buuse, Elizabeth Scarr, Brian Dean and Anthony J. Hannan

The International Journal of Neuropsychopharmacology (2009), 12:45-60

 

GRATIS 3 - The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)

Linda Hanssens, Gilbert L'Italien, Jean-Yves Loze, Ronald N Marcus, Miranda Pans and Wendy Kerselaers

BMC Psychiatry 2008, 8:95

 

3 - Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence?

Leslie Citrome

Expert Review of Neurotherapeutics. January 2009, Vol. 9, No. 1, Pages 55-71

 

3 - GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability

Erminio Costa, Ying Chen, Erbo Dong, Dennis R Grayson, Marija Kundakovic, Ekrem Maloku, William (Brad) Ruzicka, Rosalba Satta, Marin Veldic, Adrian Zhubi and Alessandro Guidotti

Expert Review of Neurotherapeutics. January 2009, Vol. 9, No. 1, Pages 87-98

 

3 - Obsessive–compulsive symptoms in schizophrenia: prevalence, correlates and treatment

Paul H Lysaker and Kriscinda A Whitney

Expert Review of Neurotherapeutics. January 2009, Vol. 9, No. 1, Pages 99-107

 

3! - Ultrasound bone mass in schizophrenic patients on antipsychotic therapy

Purificación Rey-Sánchez, Jesús M Lavado-García, María L Canal-Macías, María A Gómez-Zubeldia, Raúl Roncero-Martín, Juan D Pedrera-Zamorano

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 1, Pages 49 - 54

 

3 - Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia

Seung-Gul Kang, Heon-Jeong Lee, Jung-Eun Choi, Hyonggin An, MinKyu Rhee, Leen Kim

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 1, Pages 55 - 60

 

5 - Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

Michael Kluge, Andreas Schuld, Alexander Schacht, Hubertus Himmerich, Mira A. Dalal, Peter M. Wehmeier, Dunja Hinze-Selch, Thomas Kraus, Ralf W. Dittmann and Thomas Pollmächer

Psychoneuroendocrinology. Volume 34, Issue 1, January 2009, Pages 118-128

 

3 - Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia

Beata Konarzewska, Sławomir Wołczyński, Agata Szulc, Beata Galińska, Regina Popławska and Napoleon Waszkiewicz

Psychoneuroendocrinology. Volume 34, Issue 1, January 2009, Pages 129-139

 

3! - Antipsychotic treatment discontinuation in previously untreated patients with schizophrenia: 36-month results from the SOHO study

Josep Maria Haro, Diego Novick, David Suarez and Mercedes Roca

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 265-273

 

3! - Differential effects of ziprasidone and haloperidol on immobilization stress-induced mRNA BDNF expression in the hippocampus and neocortex of rats

Sung Woo Park, Chan Hong Lee, Jung Goo Lee, Sun Jung Lee, Na Ri Kim, Sang Mi Choi and Young Hoon Kim

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 274-281

 

3 - Effects of risperidone on glutamate receptor subtypes in developing rat brain

Yong Kee Choi, Matthew P. Gardner and Frank I. Tarazi

European Neuropsychopharmacology. Volume 19, Issue 2, February 2009, Pages 77-84

 

3 - Antipsychotic drugs modulate Arc expression in the rat brain

Fabio Fumagalli, Angelisa Frasca, Giorgio Racagni and Marco Andrea Riva

European Neuropsychopharmacology. Volume 19, Issue 2, February 2009, Pages 109-115

 

3 - Repeated risperidone treatment increases the expression of NCAM and PSA-NCAM protein in the rat medial prefrontal cortex

Marzena Maćkowiak, Dorota Dudys, Agnieszka Chocyk and Krzysztof Wedzony

European Neuropsychopharmacology. Volume 19, Issue 2, February 2009, Pages 125-137

 

3! - Psychosis and brain volume changes during the first five years of schizophrenia

W. Cahn, M. Rais, F.P. Stigter, N.E.M. van Haren, E. Caspers, H.E. Hulshoff Pol, Z. Xu, H.G. Schnack and R.S. Kahn

European Neuropsychopharmacology. Volume 19, Issue 2, February 2009, Pages 147-151

 

3< - Aripiprazole in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: An Open-Label Study of 15 Patients

Ira D. Glick, Michael Poyurovsky, Oxana Ivanova, and Lorrin M. Koran

J Clin Psychiatry 2008;69:1856-1859

 

3! - Long-Term Antipsychotic Monotherapy for Schizophrenia: Disease Burden and Comparative Outcomes for Patients Treated With Olanzapine, Quetiapine, Risperidone, or Haloperidol Monotherapy in a Pan-Continental Observational Study

Martin Dossenbach, Jan Pecenak, Agata Szulc, Victoria Irimia, Martin Anders, Dusanka Logozar-Perkovic, Dalia Peciukaitiene, Moshe Kotler, Anatoly B. Smulevich, Teena M. West, Amanda J. Lowry, and Tamas Treuer

J Clin Psychiatry 2008;69:1901-1915

 

3 - Increased Antipsychotic Sensitivity in Elderly Patients: Evidence and Mechanisms

Hiroyuki Uchida, David C. Mamo, Benoit H. Mulsant, Bruce G. Pollock, and Shitij Kapur

J Clin Psychiatry December 16, 2008: e1-e9

 

3 - Effects of Risperidone on Procedural Learning in Antipsychotic-Naive First-Episode Schizophrenia

Margret SH Harris, Courtney L Wiseman, James L Reilly, Matcheri S Keshavan and John A Sweeney

Neuropsychopharmacology (2009) 34, 468–476

 

GRATIS 3 - A New Class of Antipsychotic Drugs. Enhancing Neurotransmission Mediated by NMDA Receptors

Guochuan E. Tsai

Psychiatric Times. 2008; Vol. 25 No. 14

.

Regresar a RESÚMENES DICIEMBRE 2008